Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
Condition(s):Peanut Allergy; Multi-food AllergyLast Updated:December 8, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Peanut Allergy; Multi-food AllergyLast Updated:December 8, 2023Active, not recruiting
Condition(s):Food HypersensitivityLast Updated:May 24, 2018Completed
Condition(s):Food Allergy; Peanut AllergyLast Updated:July 12, 2017Completed
Condition(s):Soy AllergyLast Updated:July 13, 2018Terminated
Condition(s):Allergic ReactionLast Updated:January 11, 2022Unknown status
Condition(s):Egg HypersensitivityLast Updated:October 22, 2013Completed
Condition(s):Food HypersensitivityLast Updated:June 26, 2013Completed
Condition(s):Food HypersensitivityLast Updated:March 1, 2018Completed
Condition(s):Food IgE-mediated Allergy; Immunotherapy; Omalizumab; Physiological Effects of DrugsLast Updated:November 27, 2023Recruiting
Condition(s):Anal Fissures Treatment and Oligoantigenic DietLast Updated:January 11, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.